Sanofi SA reports a 10.8% increase in Q1 net sales to €9.9 billion, with significant growth in net income and EPS. CEO Paul Hudson reaffirms the company's 2025 guidance, showcasing...
Sanofi SA announced a 10.8% increase in Q1 net sales to €9.9 billion, with notable growth in net income and EPS. CEO Paul Hudson reaffirmed the company's 2025 outlook, highlighting...
Sanofi SA reports a 10.8% annual increase in Q1 2025 net sales to €9.9 billion, with significant growth in net income and EPS, reaffirming its positive outlook for 2025.
Sanofi SA reports a 10.8% increase in Q1 2025 net sales to €9.9 billion, with significant growth in net income and EPS, affirming its 2025 financial guidance.
Sanofi S.A. plans a €3 billion share buyback from L'Oreal S.A., acquiring 29,556,650 shares at a 2.8% discount. This move reduces L'Oreal's stake to 7.2%, highlighting Sanofi's ded...
Sanofi S.A. has announced a €3 billion share buyback from L'Oreal S.A., acquiring 29,556,650 shares at €101.50 each. This move reinforces their strategic partnership and commitment...
Sanofi S.A. has announced a €3 billion share buyback from L'Oreal S.A., acquiring 2.3% of its shares at a discount. This strategic move strengthens their long-standing partnership,...
